Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Ceredase approved in Japan

June 21, 1996

Redux launched in U.S.

June 21, 1996

Research results of SomatoKine as catabolism treatment

June 21, 1996

Astra acquires worldwide rights to ALX1-11

June 21, 1996

Orquest's Healos enters clinical trials

June 21, 1996

Calcium receptor modulators from NPS Pharm.

June 21, 1996

Vivus and Astra sign Muse licensing agreement

June 14, 1996

Further aldose reductase inhibitors from Sankyo

June 14, 1996

Aldose reductase and AGE inhibitors from Nissan Chem.

June 14, 1996

Troglitazone selected for NIDDK study

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...